StockNews.com started coverage on shares of TRACON Pharmaceuticals (NASDAQ:TCON – Free Report) in a research report released on Tuesday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Other research analysts have also recently issued research reports about the stock. Robert W. Baird lowered their target price on shares of TRACON Pharmaceuticals […]
TRACON Pharmaceuticals, Inc. (NASDAQ:TCON – Get Free Report) was the target of a significant decline in short interest in the month of June. As of June 30th, there was short interest totalling 141,600 shares, a decline of 37.2% from the June 15th total of 225,300 shares. Based on an average daily volume of 268,400 shares, […]
StockNews.com started coverage on shares of TRACON Pharmaceuticals (NASDAQ:TCON – Get Rating) in a research report released on Saturday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Several other research analysts also recently weighed in on the stock. HC Wainwright reaffirmed a buy rating and set a $12.00 price objective on shares […]
TRACON Pharmaceuticals, Inc. (NASDAQ:TCON – Get Rating)’s stock price crossed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $1.31 and traded as low as $0.58. TRACON Pharmaceuticals shares last traded at $0.60, with a volume of 46,899 shares traded. Analyst Ratings Changes TCON […]
Opaleye Management Inc. lifted its position in shares of TRACON Pharmaceuticals, Inc. (NASDAQ:TCON – Get Rating) by 9.5% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 4,590,000 shares of the biopharmaceutical company’s stock after buying an additional 400,000 shares during the period. TRACON […]